| GENE_SYMBOL |
DRUG_NAME |
Ki (nM) |
IC50 (nM) |
Kd (nM) |
EC50 (nM) |
Potency (nM) |
AC50 (nM) |
Datasource |
| KLK1 |
2-[[(3S,3aR,6R,6aS)-6-phenylmethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]-[2-(4-fluorophenyl)acetyl]amino]-N-cyclohexyl-2-methylpropanamide |
NA |
221000 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
2-[[(3S,3aR,6R,6aS)-6-phenylmethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3-yl]-[2-(4-methoxyphenyl)acetyl]amino]-N-cyclohexyl-2-methylpropanamide |
NA |
125000 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
4-[(1-hydroxy-3H-2,1-benzoxaborol-3-yl)methyl]-2-(pyridin-3-ylmethoxy)benzenecarboximidamide;hydrochloride |
NA |
316227.77 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
N-(4-carbamimidoylphenyl)-2-oxo-1,3-diazinane-1-carboxamide |
NA |
630957.34 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
N-(4-carbamimidoylphenyl)-1-methylbenzimidazole-2-carboxamide |
NA |
199526.23 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxymethyl]benzenecarboximidamide;hydrochloride |
NA |
158489.32 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
N-(4-carbamimidoylphenyl)-2-oxopiperidine-3-carboxamide |
NA |
501187.23 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
4-[(1-Methylimidazol-2-yl)methylamino]benzenecarboximidamide;hydrochloride |
NA |
398107.17 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
4-[(1-hydroxy-3H-2,1-benzoxaborol-7-yl)oxymethyl]benzenecarboximidamide;hydrochloride |
NA |
501187.23 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
3-[(1-hydroxy-3H-2,1-benzoxaborol-6-yl)oxymethyl]benzenecarboximidamide;hydrochloride |
NA |
158489.32 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
N-(4-carbamimidoylphenyl)-1-methyl-2-oxopyridine-3-carboxamide;formic acid |
NA |
501187.23 |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
morpholinocarbonyl-D-Gly(tBu)-Gly-DL-Phe(4-guanidino)-CF3 |
150000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
morpholinocarbonyl-D-Gly(tBu)-Phe-DL-Phe(4-guanidino)-CF3 |
2500000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
Boc-D-Phe-Gly(naphth-2-yl)-DL-Phe(4-guanidino)-CF3 |
223000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
1-adamantyl N-[(2R)-1-[[(2S)-1-[[1-[4-(diaminomethylideneamino)phenyl]-4,4,4-trifluoro-3-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate |
191000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
3-[(R)-2-[2-(7,7-Dimethyl-2-oxo-bicyclo[2.2.1]hept-1-yl)-ethanesulfonylamino]-3-(4-methanesulfonyl-piperazin-1-yl)-3-oxo-propyl]-benzamidine |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
3-[(R)-3-(4-Methanesulfonyl-piperazin-1-yl)-3-oxo-2-(2,2,5,7,8-pentamethyl-chroman-6-sulfonylamino)-propyl]-benzamidine |
1000000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
(2S)-1-[(2R)-2-amino-3,3-diphenylpropanoyl]-N-[1-(diaminomethylideneamino)-5,8-dioxo-8-piperidin-1-yloctan-4-yl]pyrrolidine-2-carboxamide |
199000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
6-amino-N-[(3S,7E,9S,12R,16S,19S)-16-[[3-(aminomethyl)phenyl]methyl]-12-[(2S)-butan-2-yl]-9-[(4-hydroxyphenyl)methyl]-2,6,11,14,18-pentaoxo-1,5,10,13,17-pentazabicyclo[17.3.0]docos-7-en-3-yl]hexanamide |
1300000 |
NA |
NA |
NA |
NA |
NA |
TTD |
| KLK1 |
N-[(3S,7E,9S,12R,16S,19S)-16-[[3-(aminomethyl)phenyl]methyl]-12-[(2S)-butan-2-yl]-9-[(4-hydroxyphenyl)methyl]-2,6,11,14,18-pentaoxo-1,5,10,13,17-pentazabicyclo[17.3.0]docos-7-en-3-yl]acetamide |
1800000 |
NA |
NA |
NA |
NA |
NA |
TTD |